Coronary Embolism despite CHA₂DS₂-VASc Score of Zero: Should We Reconsider Anticoagulation?


Journal

Case reports in cardiology
ISSN: 2090-6404
Titre abrégé: Case Rep Cardiol
Pays: United States
ID NLM: 101576452

Informations de publication

Date de publication:
2021
Historique:
received: 05 04 2021
accepted: 10 07 2021
entrez: 10 8 2021
pubmed: 11 8 2021
medline: 11 8 2021
Statut: epublish

Résumé

Coronary embolism (CE) is a rare but important cause of acute coronary syndrome. The most common source of emboli is considered to be infective endocarditis and atrial fibrillation. Various studies have estimated the prevalence of coronary embolism; however, diagnosis is challenging. Often, it is difficult to differentiate. Nonetheless, this is an important step as treating the underlying cause of an embolism is essential to limit recurrence. However, while this condition may have fatal consequences, due to its uncommon occurrence, there is no consensus on diagnosis and management. We present a case of a 53-year-old obese male, with a history of paroxysmal atrial fibrillation not on anticoagulation due to a low CHA

Identifiants

pubmed: 34373792
doi: 10.1155/2021/9912245
pmc: PMC8349250
doi:

Types de publication

Case Reports

Langues

eng

Pagination

9912245

Informations de copyright

Copyright © 2021 Ammar Ahmed et al.

Déclaration de conflit d'intérêts

None of the coauthors of this case report have any conflict of interest or any financial disclosures.

Références

J Am Coll Cardiol. 2019 Jul 9;74(1):104-132
pubmed: 30703431
JACC Cardiovasc Interv. 2018 Jan 22;11(2):172-180
pubmed: 29348012
Circulation. 2015 Jul 28;132(4):223-6
pubmed: 26216083
Europace. 2018 Sep 1;20(9):1412-1419
pubmed: 29228158
Blood. 1998 Oct 1;92(7):2353-8
pubmed: 9746774
Int J Cardiol. 2020 Feb 15;301:103-107
pubmed: 31787387
Ann Intern Med. 1978 Feb;88(2):155-61
pubmed: 626443
Circulation. 2015 Jul 28;132(4):241-50
pubmed: 26216084
Clin Cardiol. 2015 Aug;38(8):476-82
pubmed: 26248681
Chest. 2008 Jun;133(6 Suppl):546S-592S
pubmed: 18574273
Lancet. 2009 Jan 10;373(9658):155-66
pubmed: 19135613
Cardiovasc Revasc Med. 2020 Mar;21(3):367-374
pubmed: 31178350
Circ Cardiovasc Interv. 2017 Oct;10(10):
pubmed: 29042400
Cardiovasc Clin. 1989;20(1):29-104
pubmed: 2653639

Auteurs

Ammar Ahmed (A)

Department of Internal Medicine, Ascension Providence Hospital, Southfield, MI, USA.

Andrew Assaf (A)

Department of Cardiovascular Disease, Ascension Providence Hospital, Southfield, MI, USA.

Aditi Shankar (A)

Department of Internal Medicine, Texas Health Presbyterian Dallas, Dallas, TX, USA.

Marcel Zughaib (M)

Department of Cardiovascular Disease, Ascension Providence Hospital, Southfield, MI, USA.

Classifications MeSH